RadNet, Inc. (RDNT) Reports Record Q4 2025 Revenue and EBITDA, Digital Health Segment Surges 48%
RadNet, Inc. (RDNT) delivered a robust performance in Q4 2025, with revenue climbing 14.8% to $547.7 million, driven by growth in imaging center operations and operational efficiencies. Adjusted EBITDA ROSE 16.9% to $87.7 million, reflecting strong procedural volumes and cost management. The Digital Health segment stood out with a 48.2% revenue surge to $27.9 million, bolstered by AI-driven subscription stability.
MRI, CT, and PET/CT volumes posted double-digit growth, with same-center performance remaining resilient. The company's 2026 guidance projects imaging revenue growth of 17–19%, EBITDA expansion of 18–22%, and free cash Flow increasing by 29–41%. Strategic moves, including the Gleamer acquisition and planned FDA clearances, aim to further solidify RadNet's AI capabilities.
Despite closing at $69.81, down 3.16%, pre-market trading saw a rebound to $74.50, signaling investor confidence in the company's trajectory.
